- Study shows that insulin prices could be much lower and drug makers would still make healthy profits https://gh.bmj.com/content/3/5/e000850 5 comments science
- Study shows that insulin prices could be much lower and drug makers would still make healthy profits https://gh.bmj.com/content/3/5/e000850 3 comments science
- Study shows that insulin prices could be much lower and drug makers would still make healthy profits https://gh.bmj.com/content/3/5/e000850 14 comments science
- Study shows that insulin prices could be much lower and drug makers would still make healthy profits https://gh.bmj.com/content/3/5/e000850 4 comments science
- Study shows that insulin prices could be much lower and drug makers would still make healthy profits https://gh.bmj.com/content/3/5/e000850 3 comments science
- Study shows that insulin prices could be much lower and drug makers would still make healthy profits https://gh.bmj.com/content/3/5/e000850 6 comments science
- Study shows that insulin prices could be much lower and drug makers would still make healthy profits https://gh.bmj.com/content/3/5/e000850 6 comments science
- Study shows that insulin prices could be much lower and drug makers would still make healthy profits https://gh.bmj.com/content/3/5/e000850 1924 comments science
Linking pages
- FACT SHEET: By The Numbers: Millions of Americans Would Lose Health Care Coverage, Benefits, and Protections Under Congressional Republicans’ Plans | The White House https://www.whitehouse.gov/briefing-room/statements-releases/2022/11/01/fact-sheet-by-the-numbers-millions-of-americans-would-lose-health-care-coverage-benefits-and-protections-under-congressional-republicans-plans/ 73 comments
- The Price of Insulin Is a National Disgrace – Mother Jones https://www.motherjones.com/kevin-drum/2019/06/the-price-of-insulin-is-a-national-disgrace/ 55 comments
- The chaotic industry behind the insulin I need to live - The Verge https://www.theverge.com/2019/11/19/20966695/insulin-industry-diabetic-type-1-drug-price-cost-manufacturing-access 0 comments
- Eli Lilly cuts insulin prices after years of outrage | Ars Technica https://arstechnica.com/science/2023/03/eli-lilly-to-match-medicares-35-insulin-cost-cap-after-furor/ 0 comments
Related searches:
Search whole site: site:gh.bmj.com
Search title: Production costs and potential prices for biosimilars of human insulin and insulin analogues | BMJ Global Health
See how to search.